| Serotonin Receptor Blockers in Ischemic Mitral Regurgitation (NCT05469165) | Laval University | 2023-06-20 |
| Open Label Extension of Efgartigimod in Adults With Post-COVID-19 POTS (NCT05918978) | argenx | 2023-06-20 |
| A Phase 1/2 Study of CG001419 Tablets in Adult Subjects With Locally Advanced or Metastatic Solid Tumours Harbouring NTRK Gene Abnormalities (NCT07394374) | Cullgen (Shanghai),Inc | 2023-06-20 |
| Use Of Hall Technique In Deciduous Molars Affected By Extensive Caries Lesions (NCT05301439) | University of Nove de Julho | 2023-06-20 |
| HAIC Combined With Durvalumab, Tremelimumab and Bevacizumab as Conversion Therapy for Potentially Resectable Hepatocellular Carcinoma (NCT05864755) | Tianjin Medical University Cancer Institute and Hospital | 2023-06-20 |
| Radiotherapy by Sonic Hedgehog Pathway Inhibitors in Basal Cell Carcinoma (NCT05561634) | University Hospital, Lille | 2023-06-20 |
| A Phase II/III Study to Evaluate the Immunogenicity and Safety and Efficacy of SWIM816 Vaccines for SARS-CoV-2 (NCT05911087) | Stemirna Therapeutics | 2023-06-20 |
| Cryoablation Combined With Tislelizumab Plus Lenvatinib in 1L Treatment of Advanced HCC (CASTLE-10) (NCT05897268) | Fudan University | 2023-06-20 |
| Effect of Magnesium Sulphate Pretreatment in Pediatric Abdominal Surgery (NCT05736744) | Assiut University | 2023-06-20 |
| Cadonilimab as Neoadjuvant Therapy in Resectable Stage II-III MSI-H/dMMR Colorectal Cancer (NCT05913570) | LiuYing | 2023-06-20 |
| Dabrafenib Plus Trametinib in Patients With Advanced Solid Tumor Having BRAF V600E Mutation or Clinically Actionable BRAF Gene Alterations (NCT05876806) | Se Jun Park | 2023-06-20 |
| A Study to Assess the Efficacy and Safety of Daily OM-85 in Young Children With Recurrent Wheezing (NCT05857930) | OM Pharma SA | 2023-06-20 |
| Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis (IPF) (NCT05938920) | InSilico Medicine Hong Kong Limited | 2023-06-19 |
| A Study of SPH3127 in the Treatment of Mild to Moderate Ulcerative Colitis (NCT05770609) | Shanghai Pharmaceuticals Holding Co., Ltd | 2023-06-19 |
| A Clinical Study of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis (NCT05970432) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2023-06-19 |
| Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma (NCT06013618) | Sun Yat-Sen University Cancer Center | 2023-06-19 |
| The Efficacy and Safety of Fruquintinib Plus Chemotherapy as Second-line Treatment in Metastatic Colorectal Cancer (NCT05555901) | Fudan University | 2023-06-18 |
| PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer (NCT04910425) | Northwestern University | 2023-06-17 |
| Neo-adjuvant Treatment for Squamous Cell Carcinoma Using Direct Tumor Injection With RP1. (NCT05858229) | Sherrif Ibrahim | 2023-06-16 |
| Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular Dysfunction (NCT05711719) | Johns Hopkins University | 2023-06-16 |
| To Investigate Efficacy, Pharmacodynamics, and Safety of BC 007 in Participants With Long COVID (NCT05911009) | Berlin Cures GmbH | 2023-06-16 |
| IS-002 Phase 2 Prostate Cancer Study (NCT05946603) | Intuitive Surgical | 2023-06-16 |
| A Clinical Study of Recombinant Human Vascular Endothelial Inhibitor in Combination With PRaG for Advanced Refractory Non-small Cell Lung Cancer (NCT06047860) | Second Affiliated Hospital of Soochow University | 2023-06-16 |
| Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD). (NCT05893537) | Cognition Therapeutics | 2023-06-16 |
| A Study to Assess Efficacy and Safety of HH-003 Injection in Subjects With Chronic Hepatitis Delta Virus Infection (NCT05861674) | Huahui Health | 2023-06-16 |
| Study of Loncastuximab Tesirine in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) or High-Grade B-Cell Lymphoma (HGBCL) Following CAR-T Therapy Failure (NCT06918912) | Istituto Clinico Humanitas | 2023-06-16 |
| Comparison of Oral Versus Vaginal Misoprostol for Labour Induction at Term (NCT05957666) | Services Institute of Medical Sciences, Pakistan | 2023-06-16 |
| Treatment of Refractory Infantile Spasms With Fenfluramine (NCT04289467) | Children's Hospital of Orange County | 2023-06-16 |
| Cryoablation Combined With Tislelizumab Plus Lenvatinib In Previously Treated Gastric Cancer Liver Metastasis (CASTLE-09) (NCT05893056) | Fudan University | 2023-06-16 |
| Immunogenicity and Safety Study of SARS-CoV-2 DNA Vaccine (ICCOV) (NCT05904054) | Immuno Cure 3 Limited | 2023-06-15 |
| The Clinical Effects of Using Collagen Matrix in Papilla Augmentation: a Prospective Clinical Trial. Augmenting Fibro-Gide in Interdental Area Using Tunneling Technique to Treat Black Triangles (Papilla Loss) (NCT06853704) | King Abdullah University Hospital | 2023-06-15 |
| Ketohexokinase Inhibition in Hereditary Fructose Intolerance (NCT06089265) | Maastricht University Medical Center | 2023-06-15 |
| Study to Evaluate the Safety of Intravenous Oritavancin for the Treatment of Children With Skin Infections (NCT05599295) | Melinta Therapeutics, LLC | 2023-06-15 |
| Hyperinsulinemia in Prediabetes Mediated by Interleukin-1β (NCT05854251) | University Hospital, Basel, Switzerland | 2023-06-15 |
| Vancomycin in Primary Sclerosing Cholangitis in Italy (NCT05876182) | University of Milano Bicocca | 2023-06-15 |
| Evaluate the Efficacy, Safety and Tolerability of HLX26 and Serplulimab in Patients with MCRC (NCT05584137) | Shanghai Henlius Biotech | 2023-06-15 |
| Effect of Nivolumab vs Placebo in Patients With Acute Myocardial Infarction: A Randomized Clinical Trial (NCT05887830) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2023-06-15 |
| 64Cu-SAR-BBN and 67CU SAR-BBN for Identification and Treatment of Gastrin Releasing Peptide Receptor (GRPR)-Expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617 (COMBAT) (NCT05633160) | Clarity Pharmaceuticals Ltd | 2023-06-15 |
| Safety and Tolerability Subretinal OPGx-001 for LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD) and Non-interventional Arm With Untreated Patients (NCT05616793) | Opus Genetics, Inc | 2023-06-15 |
| Sacituzumab Govitecan Before Radical Cystectomy for the Treatment of Non-Urothelial Muscle Invasive Bladder Cancer (NCT05581589) | University of Washington | 2023-06-15 |
| A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments (NCT05714839) | GlaxoSmithKline | 2023-06-14 |
| A Safety and Feasibility Study of IS-001 Injection in Patients Undergoing Robotic Colorectal Surgery (NCT05769257) | Intuitive Surgical | 2023-06-14 |
| A Clinical Study of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Treatment of Non Small Cell Lung Cancer (NCT05913089) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2023-06-14 |
| A Trial of Sugemalimab and Chemotherapy in Unresectable Stage III NSCLC (NCT05940532) | Hunan Cancer Hospital | 2023-06-14 |
| EASE (Efficacy of ATX01 Study in Erythromelalgia) (NCT05917912) | AlgoTherapeutix | 2023-06-14 |
| A Study to Investigate the Safety, Tolerability and Preliminary Efficacy of NGI226 Microparticles in Patients With Achilles Tendinopathy (NCT05592990) | Novartis Pharmaceuticals | 2023-06-14 |
| POC Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Active Intermediate, Posterior, or Pan NIU (NCT05953688) | Alumis Inc | 2023-06-14 |
| Enfortumab Vedotin Schedule De-escalation in Metastatic Urothelial Carcinoma (NCT05923190) | Fox Chase Cancer Center | 2023-06-14 |
| A Study of Zimberelimab(GLS-010) Combined With AVD for Newly Diagnosed Early-stage Hodgkin's Lymphoma (NCT05900765) | Sun Yat-sen University | 2023-06-14 |
| GV1001 Subcutaneous(SC) for the Treatment of Progressive Supranuclear Palsy (PSP) (NCT05819658) | GemVax & Kael | 2023-06-14 |
| SHR1701 Alone or in Combination With SHR2554 in Relapsed or Refractory Classical Hodgkin Lymphoma (NCT05896046) | Chinese PLA General Hospital | 2023-06-14 |
| GEM+Nab-Paclitaxel Plus Losartan Followed by Stereotactic Radiotherapy for Locally Advanced Pancreatic Cancer (NCT05861336) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2023-06-14 |
| A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors (NCT05551117) | MacroGenics | 2023-06-13 |
| Efficacy and Safety of HRS9531 Injection in Obese Subjects Without Diabetes (NCT05881837) | Fujian Shengdi Pharmaceutical Co., Ltd. | 2023-06-13 |
| Vebreltinib Plus PLB1004 in EGFR-mutated, Advanced NSCLC With MET Amplification or MET Overexpression Following EGFR-TKI (NCT06343064) | Avistone Biotechnology Co., Ltd. | 2023-06-13 |
| Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer (NCT05776524) | THERABIONIC INC. | 2023-06-13 |
| A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia (NCT05926765) | MeiraGTx, LLC | 2023-06-13 |
| This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects with Moderate to Severe Atopic Dermatitis (AD). (NCT05935085) | AnaptysBio, Inc. | 2023-06-13 |
| Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer (NCT05601440) | Canadian Cancer Trials Group | 2023-06-13 |
| A Study Comparing 3 Study Medicines (Encorafenib, Binimetinib, Pembrolizumab) to 2 Study Medicines (Ipilimumab and Nivolumab) in Patients With Advanced Melanoma (NCT05926960) | Pfizer | 2023-06-13 |
| A Phase 2 Study to Evaluate the Triplet Combination of Pemetrexed Plus AB928 (Etrumadenant) + AB122 (Zimberelimab) in Patients With Previously Treated Advanced or Metastatic MTAP Deficient Urothelial Carcinoma (NCT05335941) | M.D. Anderson Cancer Center | 2023-06-13 |
| Does Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity? (NCT05895643) | Psychiatric Centre Rigshospitalet | 2023-06-13 |
| Executive Functioning Training Study (NCT05598047) | University of Alabama at Birmingham | 2023-06-13 |
| A Double-blind Randomised, Placebo-controlled Clinical Trial to Test Ambroxol Treatment in ALS (NCT05959850) | The Florey Institute of Neuroscience and Mental Health | 2023-06-13 |
| OM202JP Clinical Study of KNP2002 (NCT05896215) | KinoPharma Inc. | 2023-06-12 |
| Gemcitabine Versus Reduced-dose Combination Chemotherapy in Fragile Patients with Non-resectable Pancreatic Cancer (NCT05841420) | Morten Ladekarl | 2023-06-12 |
| Omega-3 Fatty Acid Lipidomics in Diabetes Peripheral Neuropathy (NCT05169060) | University of Iowa | 2023-06-12 |
| A 2-part Study Consisting of Multiple Ascending Dose (MAD) Safety Study, and a Dose-finding Masked Study to Assess the Safety and Efficacy of Intravitreal (IVT) EYE103 in Patients With Diabetic Macular Edema (DME) or Neovascular Age-related Macular Degeneration (NVAMD) (NCT05919693) | EyeBiotech Ltd. | 2023-06-12 |
| A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Netherton Syndrome (NCT05856526) | Boehringer Ingelheim | 2023-06-12 |
| Safety and Efficacy of the PAINLESS Nerve Growth Factor CHF6467 in Optic Pathway Glioma (OPG) (NCT05733572) | Benedetto Falsini | 2023-06-12 |
| Adagrasib in Patients With KRASG12C-mutant NSCLC Who Are Elderly or Have Poor Performance Status (NCT05673187) | ETOP IBCSG Partners Foundation | 2023-06-12 |
| Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer (NCT05826964) | University of Miami | 2023-06-12 |
| Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (NCT05633615) | SWOG Cancer Research Network | 2023-06-12 |
| Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients (NCT05821556) | National Cancer Institute, Naples | 2023-06-12 |
| Free Samples for Health (NCT05627596) | Sandra Japuntich | 2023-06-12 |
| Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors (NCT05887492) | Tango Therapeutics, Inc. | 2023-06-12 |
| Domvanalimab and Zimberelimab in Advanced Liver Cancers (NCT05724563) | University of Texas Southwestern Medical Center | 2023-06-12 |
| A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy (NCT05361798) | National Cancer Institute (NCI) | 2023-06-12 |
| Pembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast Cancer (NCT05491083) | National University Hospital, Singapore | 2023-06-12 |
| Diagnostic Value of CXCR4-targeted PET/CT in ACTH-dependent and Independent Cushing's Syndrome (NCT07350707) | Peking Union Medical College Hospital | 2023-06-12 |
| Coenzyme Q10 and Dentoalveolar Cyst (NCT05873673) | Fayoum University | 2023-06-11 |
| A Combination Study of CAR-T Therapy in r/r B-NHL (NCT05871684) | Ruijin Hospital | 2023-06-10 |
| Safety and Immunogenicity of HIL-214 With Routine Pediatric Vaccines (NCT05836012) | HilleVax | 2023-06-10 |
| Neoadjuvant Chemo-hypoRT Plus PD-1 Antibody (Tislelizumab) in Resectable LA-G/GEJ (NCT05941481) | Jiangsu Cancer Institute & Hospital | 2023-06-10 |
| Effects of Paroxetine on Cardiovascular Function in Septic Patients (NCT05725837) | Universidade do Extremo Sul Catarinense - Unidade Academica de Ciecias da Saude | 2023-06-10 |
| Combination of DV and Tislelizumab for Renal Preservation in High-risk UTUC Patients (NCT05912816) | RenJi Hospital | 2023-06-10 |
| Comparing Inotuzumab Combined With Low Intensity Chemotherapy Plus Blinatumomab to Usual Chemotherapy Plus Blinatumomab in Older Adults With CD22+ B-cell Acute Lymphoblastic Leukemia (NCT05303792) | Alliance for Clinical Trials in Oncology | 2023-06-09 |
| RMP-A03 Ocular Suspension in Patients With Pterygium (NCT05794204) | Suzhou Raymon Pharmaceuticals Company, Ltd. | 2023-06-09 |
| A Phase I/IIa Clinical Study to Assess the Single and Multiple Ascending Doses of MDR-001 Tablets in Healthy Participants and Obese/ Overweight Participants (NCT06778850) | MindRank AI Ltd | 2023-06-09 |
| Study of INV-102 Ophthalmic Solution in Adults With Acute Infectious Keratoconjunctivitis (NCT05636228) | Invirsa, Inc. | 2023-06-09 |
| Study of LP-184 in Patients With Advanced Solid Tumors (NCT05933265) | Lantern Pharma Inc. | 2023-06-09 |
| A Study of IO102/IO103, Nivolumab, and Relatlimab in People With Melanoma (NCT05912244) | Memorial Sloan Kettering Cancer Center | 2023-06-09 |
| Study of ALTO-300 in MDD (NCT05922878) | Alto Neuroscience | 2023-06-08 |
| RC48-ADC in Combination With Gemcitabine in High Risk NMIBC Subjects (NCT05943379) | RemeGen Co., Ltd. | 2023-06-08 |
| ARTEMIS-002: HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other Sarcomas (NCT05830123) | Hansoh BioMedical R&D Company | 2023-06-08 |
| Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients (NCT05695261) | Rima Rachid | 2023-06-08 |
| Neural Correlates During Alcohol Intoxication (NCT06118580) | Ohio State University | 2023-06-08 |
| Open-label, Multi-centre, Non-Inferiority Study of Safety and Immunogenicity of BIMERVAX for the Prevention of COVID-19 in Adolescents From 12 Years to Less Than 18 Years of Age. (NCT06234956) | Hipra Scientific, S.L.U | 2023-06-08 |
| A Study of GZR18 Injection in Obese/Overweight Patients (NCT06256562) | Gan and Lee Pharmaceuticals, USA | 2023-06-08 |
| From Nerve to Brain: Toward a Mechanistic Understanding of Spinal Cord Stimulation in Human Subjects (NCT05661903) | Massachusetts General Hospital | 2023-06-08 |